Product Code: ANV781
REPORT HIGHLIGHT
The Cancer/Tumor Profiling market is estimated to be worth US$ 7,906.1 million in 2020. Cancer/Tumor Profiling market is expected to expand at a 20.2% CAGR during the forecast period.
Market Introduction
Cancer/tumor profiling gives information on the genes that cause cancer, which can help researchers better understand how cancer works. Cancer profiling is helpful not just in the molecular diagnosis of common cancers like breast cancer and lymphoma, but also in the diagnosis of acute leukemia, prostate cancer, and lung cancer. Cancer profiling has become increasingly important in molecular diagnosis since a better understanding of cancer and tumors allows clinicians to make more informed therapeutic decisions and prevent over-treating cancer patients.
Market Dynamics
The growing demand of Oncologists for cancer profiling methods to diagnose or treat malignancies, as well as forecast response to targeted therapy, is driving the global market. In addition to this, an increase in the use of cancer biomarkers for tumor profiling, coupled with increasing incidences of cancer and an increase in the application of od sequencing techniques such as NGS techniques for cancer profiling also provide lucrative growth opportunities for global cancer/tumor profiling market. However, the growth of the global market is hampered by expensive monetary investments in biomarker research and a scarcity of experienced specialists or oncologists that specialize in tumor profiling. The pandemic had a relatively negative on the global market. Because of the COVID-19 outbreak, there has been a significant decline in cancer testing and detection due to coronavirus-related measures and resources. However, because of the high incidences of cancer in COVID-19 patients, cancer has been recognized as a high-risk factor for COVID-19. Further studies are being conducted in this area in order to better understand the dynamics of infection, which is likely to advance the cancer research sector. However, it is expected that majority of cancer diagnostic and prognostic tests, as well as tailored therapy, will rise at a steady rate over the next five years. Surgeries, chemotherapy rounds as well as radiation therapy have all been postponed significantly.
Segmentation Analysis
The Cancer/Tumor Profiling Market is segmented by technology, technique, application, regional distribution, and competitive landscape. Based on technique, the Genomics segment occupies the largest share, followed by Proteomics. The growing use of genomics for cancer diagnosis and prognosis, as well as in the biomarker development process, accounts for the largest share of this segment. The proteomic segment, on the other hand, is expected to witness a lucrative growth and rise at the fastest CAGR during the forecast period, owing to the growing use of proteomic methodologies for biomarker research in order to enhance the drug development process. They also demonstrate effectiveness in personalizing cancer treatment and monitoring. In addition to the growing pace of research and development on cancer biomarkers and advancements in technology also support the growth of the worldwide market.
Competitive Landscape
The global Cancer/Tumor Profiling market is highly competitive in nature and is dominated by a few local and international players. Major players in the industry engage in strategic mergers & acquisitions, partnerships, and new product launches to remain competent in the market. For instance, in March 2022, Illumina launched a new in vitro diagnostic test kit, TruSight Oncology Comprehensive test kit, in Europe that profiles cancer mutations and examines multiple cancer genes.
Key features of the study:
This proposed research study on Cancer/Tumor Profiling market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2021-2027), considering 2020 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer/Tumor Profiling market.
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer/Tumor Profiling market.
Impact of COVID-19 on Cancer/Tumor Profiling market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer/Tumor Profiling market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Cancer/Tumor Profiling market, we have also included competitive landscape and key innovator analysis for the Cancer/Tumor Profiling market
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Cancer/Tumor Profiling market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The Cancer/Tumor Profiling market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
Cancer/Tumor Profiling Market Key Players
NeoGenomics Laboratories
Illumina
Helomics Corporation
HTG Molecular Diagnostics
Caris Life Sciences
Genomic Health
Ribomed Biotechnologies
NanoString Technologies
QIAGEN N.V.
Sysmex Corporation
Guardant Health
Roche Diagnostics
Cancer/Tumor Profiling Market by Technology
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunoassays
Mass Spectrometry
In-Situ Hybridization
Microarrays
Others
Cancer/Tumor Profiling Market by Technique
Proteomics
Genomics
Metabolomics
Epigenetics
Cancer/Tumor Profiling Market by Application
Biomarker Discovery
Diagnostics
Prognostics
Personalized Medicine
Research Applications
Cancer/Tumor Profiling Market by Region
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
TABLE OF CONTENT
1. Cancer/Tumor Profiling Market Overview
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Market Snippet by Technology
- 2.1.2. Market Snippet by Technique
- 2.1.3. Market Snippet by Application
- 2.1.4. Market Snippet by Region
- 2.2. Competitive Insights
3. Cancer/Tumor Profiling Key Market Trends
- 3.1. Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Future Trends
4. Cancer/Tumor Profiling Industry Study
- 4.1. Porter's Five Forces Analysis
- 4.2. Marketing Strategy Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Cancer/Tumor Profiling Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Cancer/Tumor Profiling Market Landscape
- 6.1. Market Share Analysis, 2019
- 6.2. Key Innovators Analysis
- 6.3. Breakdown Data, by Key Manufacturer
- 6.3.1. Established Players' Analysis
- 6.3.2. Emerging Players' Analysis
7. Cancer/Tumor Profiling Market - By Technology
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Technology, 2020 & 2027 (%)
- 7.1.2. Next-Generation Sequencing (NGS)
- 7.1.3. Polymerase Chain Reaction (PCR)
- 7.1.4. Immunoassays
- 7.1.5. Mass Spectrometry
- 7.1.6. In-Situ Hybridization
- 7.1.7. Microarrays
- 7.1.8. Others
8. Cancer/Tumor Profiling Market - By Technique
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Technique, 2020 & 2027 (%)
- 8.1.2. Proteomics
- 8.1.3. Genomics
- 8.1.4. Metabolomics
- 8.1.5. Epigenetics
9. Cancer/Tumor Profiling Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2020 & 2027 (%)
- 9.1.2. Biomarker Discovery
- 9.1.3. Diagnostics
- 9.1.4. Prognostics
- 9.1.5. Personalized Medicine
- 9.1.6. Research Applications
10. Cancer/Tumor Profiling Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.1. U.S. Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.2. U.S. Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.3. U.S. Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.2.8. Canada
- 1.1.1.4. Overview
- 1.1.1.5. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.1. Canada Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.2. Canada Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.3. Canada Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.3.7. Germany
- 1.1.1.6. Overview
- 1.1.1.7. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.8. Germany Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.9. Germany Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.10. Germany Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.3.8. Italy
- 1.1.1.11. Overview
- 1.1.1.12. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.13. Italy Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.14. Italy Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.15. Italy Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.3.9. United Kingdom
- 1.1.1.16. Overview
- 1.1.1.17. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.18. United Kingdom Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.19. United Kingdom Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.20. United Kingdom Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.3.10. France
- 1.1.1.21. Overview
- 1.1.1.22. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.23. France Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.24. France Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.25. France Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.3.11. Rest of Europe
- 1.1.1.26. Overview
- 1.1.1.27. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.28. Rest of the Europe Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.29. Rest of the Europe Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.30. Rest of the Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.4.7. India
- 1.1.1.31. Overview
- 1.1.1.32. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.33. India Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.34. India Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.35. India Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.4.8. China
- 1.1.1.36. Overview
- 1.1.1.37. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.38. China Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.39. China Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.40. China Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.4.9. Japan
- 1.1.1.41. Overview
- 1.1.1.42. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.43. Japan Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.44. Japan Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.45. Japan Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.4.10. South Korea
- 1.1.1.46. Overview
- 1.1.1.47. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.48. South Korea Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.49. South Korea Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.50. South Korea Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.4.11. Rest of APAC
- 1.1.1.51. Overview
- 1.1.1.52. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.53. Rest of APAC Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.54. Rest of APAC Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.55. Rest of APAC Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.5.7. Brazil
- 1.1.1.56. Overview
- 1.1.1.57. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.58. Brazil Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.59. Brazil Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.60. Brazil Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.5.8. Mexico
- 1.1.1.61. Overview
- 1.1.1.62. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.63. Mexico Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.64. Mexico Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.65. Mexico Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.5.9. Argentina
- 1.1.1.66. Overview
- 1.1.1.67. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.68. Argentina Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.69. Argentina Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 1.1.1.70. Rest of LATAM Argentina Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.71. Overview
- 1.1.1.72. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.73. Rest of LATAM Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.74. Rest of LATAM Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.75. Rest of LATAM Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.6.7. Saudi Arabia
- 1.1.1.76. Overview
- 1.1.1.77. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.78. Saudi Arabia Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.79. Saudi Arabia Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.80. Saudi Arabia Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
- 10.6.8. United Arab Emirates
- 1.1.1.81. Overview
- 1.1.1.82. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
- 1.1.1.83. United Arab Emirates Market Size and Forecast, By Technology, 2016 - 2027 (US$ Million)
- 1.1.1.84. United Arab Emirates Market Size and Forecast, By Technique, 2016 - 2027 (US$ Million)
- 1.1.1.85. United Arab Emirates Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
11. Key Vendor Analysis
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. NeoGenomics Laboratories
- 11.2.2. Illumina
- 11.2.3. Helomics Corporation
- 11.2.4. HTG Molecular Diagnostics
- 11.2.5. Caris Life Sciences
- 11.2.6. Genomic Health
- 11.2.7. Ribomed Biotechnologies
- 11.2.8. NanoString Technologies
- 11.2.9. QIAGEN N.V.
- 11.2.10. Sysmex Corporation
- 11.2.11. Guardant Health
- 11.2.12. Roche Diagnostics
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us